#BEGIN_DRUGCARD DB02945

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
3402-98-0

# ChEBI_ID:
28481

# Chemical_Formula:
C6H10O7

# Chemical_IUPAC_Name:
(2S,3R,4R,5S,6S)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
L-Iduronic Acid

# HET_ID:
IDR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/t1-,2-,3+,4+,6+/m1/s1

# InChI_Key:
InChIKey=AEMOLEFTQBMNLQ-CLQWQSTFSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C06472

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2945

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
194.1394

# Molecular_Weight_Mono:
194.042652674

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1HM2

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.3

# Predicted_LogS:
0.18

# Predicted_Water_Solubility:
2.95e+02 g/l

# Primary_Accession_No:
DB02945

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01842

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:41 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U27583

# Drug_Target_1_GenBank_ID_Protein:
1002525

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cslA

# Drug_Target_1_Gene_Sequence:
>2103 bp
ATGAAGAAATTATTTGTAACCTGTATAGTCTTTTTCTCTATTTTAAGTCCTGCTCTGCTT
ATTGCACAGCAGACCGGTACTGCAGAACTGATTATGAAGCGGGTGATGCTGGACCTTAAA
AAGCCTTTGCGCAATATGGATAAGGTGGCGGAAAAGAACCTGAATACGCTGCAGCCTGAC
GGTAGCTGGAAGGATGTGCCTTATAAAGATGATGCCATGACCAATTGGTTGCCAAACAAC
CACCTGCTACAATTGGAAACTATTATACAGGCTTATATTGAAAAAGATAGTCACTATTAT
GGCGACGATAAAGTGTTTGACCAGATTTCCAAAGCTTTTAAGTATTGGTATGACAGCGAC
CCGAAAAGCCGCAACTGGTGGCACAATGAAATTGCCACTCCGCAGGCCCTTGGTGAAATG
CTGATCCTGATGCGTTACGGTAAAAAGCCGCTTGATGAAGCATTGGTGCATAAATTGACC
GAAAGAATGAAGCGGGGCGAACCGGAGAAGAAAACGGGGGCCAACAAAACAGATATCGCC
CTGCATTACTTTTATCGTGCTTTGTTAACGTCTGATGAGGCTTTGCTTTCCTTCGCCGTA
AAAGAATTGTTTTATCCCGTACAGTTTGTACACTATGAGGAAGGCCTGCAATACGATTAT
TCCTACCTGCAGCACGGTCCGCAATTACAGATATCGAGCTACGGTGCCGTATTTATTACC
GGGGTACTGAAACTTGCCAATTACGTTAGGGATACCCCTTATGCTTTAAGTACCGAGAAA
CTGGCTATATTTTCAAAGTATTACCGCGACAGTTATCTGAAAGCTATCCGTGGAAGTTAT
ATGGATTTTAACGTAGAAGGCCGCGGAGTAAGCCGGCCAGACATTCTAAATAAAAAGGCA
GAAAAAAAGAGGTTGCTGGTGGCGAAGATGATCGATCTTAAGCATACTGAAGAATGGGCT
GATGCGATAGCCAGGACAGATAGCACAGTTGCGGCCGGCTATAAGATTGAGCCCTATCAC
CATCAGTTCTGGAATGGTGATTATGTGCAACATTTAAGACCTGCCTATTCTTTTAATGTT
CGTATGGTGAGTAAGCGGACCCGACGCAGTGAATCCGGCAATAAAGAAAACCTGCTGGGC
AGGTATTTATCTGATGGGGCTACTAACATACAATTGCGCGGACCAGAATACTATAACATT
ATGCCGGTATGGGAATGGGACAAGATTCCTGGCATAACCAGCCGTGATTATTTAACCGAC
AGACCTTTGACGAAGCTTTGGGGAGAGCAGGGGAGCAATGACTTTGCAGGAGGGGTGTCT
GATGGTGTATACGGGGCCAGTGCCTACGCATTGGATTACGATAGCTTACAGGCAAAGAAA
GCCTGGTTCTTTTTTGACAAAGAGATTGTATGTCTTGGTGCCGGTATCAACAGCAATGCC
CCTGAAAACATTACCACTACCCTTAACCAGAGCTGGTTAAATGGCCCGGTTATAAGTACT
GCAGGTAAAACCGGCCGGGGTAAAATAACAACGTTTAAAGCACAGGGACAGTTCTGGTTG
TTGCACGATGCGATTGGTTATTACTTTCCTGAAGGGGCCAACCTTAGTCTGAGTACCCAG
TCGCAAAAAGGCAATTGGTTCCACATCAACAATTCACATTCAAAAGATGAAGTTTCTGGT
GATGTATTTAAGCTTTGGATCAACCATGGTGCCAGGCCAGAAAATGCGCAGTATGCTTAT
ATCGTTTTGCCGGGAATAAACAAGCCGGAAGAAATTAAAAAATATAATGGAACGGCACCG
AAAGTCCTTGCCAATACCAACCAGCTGCAGGCAGTTTATCATCAGCAGTTAGATATGGTA
CAGGCTATCTTCTATACAGCTGGAAAATTAAGCGTAGCGGGCATAGAAATTGAAACAGAT
AAGCCATGTGCAGTGCTGATCAAGCACATCAATGGCAAGCAGGTAATTTGGGCTGCCGAT
CCATTGCAAAAAGAAAAGACTGCAGTGTTGAGCATCAGGGATTTAAAAACAGGAAAAACA
AATCGGGTAAAAATTGATTTTCCGCAACAGGAATTTGCAGGTGCAACGGTTGAACTGAAA
TAG

# Drug_Target_1_General_Function:
Involved in catalytic activity

# Drug_Target_1_General_References:
10329169	Fethiere J, Eggimann B, Cygler M: Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes. J Mol Biol. 1999 May 14;288(4):635-47.
10618199	Tkalec AL, Fink D, Blain F, Zhang-Sun G, Laliberte M, Bennett DC, Gu K, Zimmermann JJ, Su H: Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum. Appl Environ Microbiol. 2000 Jan;66(1):29-35.
11327856	Huang W, Boju L, Tkalec L, Su H, Yang HO, Gunay NS, Linhardt RJ, Kim YS, Matte A, Cygler M: Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry. 2001 Feb 27;40(8):2359-72.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2581

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
79695

# Drug_Target_1_Name:
Chondroitinase AC

# Drug_Target_1_Number_of_Residues:
700

# Drug_Target_1_PDB_ID:
1HMW

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02278	Lyase_8
PF02884	Lyase_8_C
PF08124	Lyase_8_N

# Drug_Target_1_Protein_Sequence:
>Chondroitinase AC precursor
MKKLFVTCIVFFSILSPALLIAQQTGTAELIMKRVMLDLKKPLRNMDKVAEKNLNTLQPD
GSWKDVPYKDDAMTNWLPNNHLLQLETIIQAYIEKDSHYYGDDKVFDQISKAFKYWYDSD
PKSRNWWHNEIATPQALGEMLILMRYGKKPLDEALVHKLTERMKRGEPEKKTGANKTDIA
LHYFYRALLTSDEALLSFAVKELFYPVQFVHYEEGLQYDYSYLQHGPQLQISSYGAVFIT
GVLKLANYVRDTPYALSTEKLAIFSKYYRDSYLKAIRGSYMDFNVEGRGVSRPDILNKKA
EKKRLLVAKMIDLKHTEEWADAIARTDSTVAAGYKIEPYHHQFWNGDYVQHLRPAYSFNV
RMVSKRTRRSESGNKENLLGRYLSDGATNIQLRGPEYYNIMPVWEWDKIPGITSRDYLTD
RPLTKLWGEQGSNDFAGGVSDGVYGASAYALDYDSLQAKKAWFFFDKEIVCLGAGINSNA
PENITTTLNQSWLNGPVISTAGKTGRGKITTFKAQGQFWLLHDAIGYYFPEGANLSLSTQ
SQKGNWFHINNSHSKDEVSGDVFKLWINHGARPENAQYAYIVLPGINKPEEIKKYNGTAP
KVLANTNQLQAVYHQQLDMVQAIFYTAGKLSVAGIEIETDKPCAVLIKHINGKQVIWAAD
PLQKEKTAVLSIRDLKTGKTNRVKIDFPQQEFAGATVELK

# Drug_Target_1_Reaction:
Eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups

# Drug_Target_1_Signals:
1-22

# Drug_Target_1_Specific_Function:
Eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4- enuronosyl groups

# Drug_Target_1_SwissProt_ID:
Q59288

# Drug_Target_1_SwissProt_Name:
CSLA_PEDHD

# Drug_Target_1_Synonyms:
Chondroitin AC eliminase
Chondroitin AC lyase
Chondroitin sulfate AC lyase
Chondroitinase AC precursor
EC 4.2.2.5

# Drug_Target_1_Theoretical_pI:
9.19

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02945
